Quetiapine Fumarate Industry Research Report 2024
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
According to APO Research, the global Quetiapine Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Quetiapine Fumarate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Quetiapine Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Quetiapine Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- AstraZeneca
- Intas
- TAPI
- Accord
- Hexal
- Dr.Reddy's
- Lupin
- Sun Pharmaceutical
- Hunan Dongting Pharm
- SuZhou NO.4 Phamaceutical Factory
- Fuan Pharmaceutical
- Zhejiang Supor Pharmaceuticals
- Zhejiang Huahai Pharmaceutical
- Immediate Release Tablets
- Extended Release Tablets
- Adult
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Quetiapine Fumarate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Quetiapine Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Quetiapine Fumarate Market Size (2019-2030) & (US$ Million)
2.2.2 Global Quetiapine Fumarate Sales (2019-2030)
2.2.3 Global Quetiapine Fumarate Market Average Price (2019-2030)
2.3 Quetiapine Fumarate by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Immediate Release Tablets
2.3.3 Extended Release Tablets
2.4 Quetiapine Fumarate by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Adult
2.4.3 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Quetiapine Fumarate Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Quetiapine Fumarate Sales (MT) of Manufacturers (2019-2024)
3.3 Global Quetiapine Fumarate Revenue of Manufacturers (2019-2024)
3.4 Global Quetiapine Fumarate Average Price by Manufacturers (2019-2024)
3.5 Global Quetiapine Fumarate Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Quetiapine Fumarate, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Quetiapine Fumarate, Product Type & Application
3.8 Global Manufacturers of Quetiapine Fumarate, Date of Enter into This Industry
3.9 Global Quetiapine Fumarate Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 AstraZeneca
4.1.1 AstraZeneca Company Information
4.1.2 AstraZeneca Business Overview
4.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
4.1.5 AstraZeneca Recent Developments
4.2 Intas
4.2.1 Intas Company Information
4.2.2 Intas Business Overview
4.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Intas Quetiapine Fumarate Product Portfolio
4.2.5 Intas Recent Developments
4.3 TAPI
4.3.1 TAPI Company Information
4.3.2 TAPI Business Overview
4.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.3.4 TAPI Quetiapine Fumarate Product Portfolio
4.3.5 TAPI Recent Developments
4.4 Accord
4.4.1 Accord Company Information
4.4.2 Accord Business Overview
4.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Accord Quetiapine Fumarate Product Portfolio
4.4.5 Accord Recent Developments
4.5 Hexal
4.5.1 Hexal Company Information
4.5.2 Hexal Business Overview
4.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Hexal Quetiapine Fumarate Product Portfolio
4.5.5 Hexal Recent Developments
4.6 Dr.Reddy's
4.6.1 Dr.Reddy's Company Information
4.6.2 Dr.Reddy's Business Overview
4.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
4.6.5 Dr.Reddy's Recent Developments
4.7 Lupin
4.7.1 Lupin Company Information
4.7.2 Lupin Business Overview
4.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Lupin Quetiapine Fumarate Product Portfolio
4.7.5 Lupin Recent Developments
4.8 Sun Pharmaceutical
4.8.1 Sun Pharmaceutical Company Information
4.8.2 Sun Pharmaceutical Business Overview
4.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
4.8.5 Sun Pharmaceutical Recent Developments
4.9 Hunan Dongting Pharm
4.9.1 Hunan Dongting Pharm Company Information
4.9.2 Hunan Dongting Pharm Business Overview
4.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
4.9.5 Hunan Dongting Pharm Recent Developments
4.10 SuZhou NO.4 Phamaceutical Factory
4.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
4.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
4.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
4.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
4.11 Fuan Pharmaceutical
4.11.1 Fuan Pharmaceutical Company Information
4.11.2 Fuan Pharmaceutical Business Overview
4.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
4.11.5 Fuan Pharmaceutical Recent Developments
4.12 Zhejiang Supor Pharmaceuticals
4.12.1 Zhejiang Supor Pharmaceuticals Company Information
4.12.2 Zhejiang Supor Pharmaceuticals Business Overview
4.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
4.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
4.13 Zhejiang Huahai Pharmaceutical
4.13.1 Zhejiang Huahai Pharmaceutical Company Information
4.13.2 Zhejiang Huahai Pharmaceutical Business Overview
4.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
4.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
5 GLOBAL QUETIAPINE FUMARATE MARKET SCENARIO BY REGION
5.1 Global Quetiapine Fumarate Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Quetiapine Fumarate Sales by Region: 2019-2030
5.2.1 Global Quetiapine Fumarate Sales by Region: 2019-2024
5.2.2 Global Quetiapine Fumarate Sales by Region: 2025-2030
5.3 Global Quetiapine Fumarate Revenue by Region: 2019-2030
5.3.1 Global Quetiapine Fumarate Revenue by Region: 2019-2024
5.3.2 Global Quetiapine Fumarate Revenue by Region: 2025-2030
5.4 North America Quetiapine Fumarate Market Facts & Figures by Country
5.4.1 North America Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Quetiapine Fumarate Sales by Country (2019-2030)
5.4.3 North America Quetiapine Fumarate Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Quetiapine Fumarate Market Facts & Figures by Country
5.5.1 Europe Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Quetiapine Fumarate Sales by Country (2019-2030)
5.5.3 Europe Quetiapine Fumarate Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Country
5.6.1 Asia Pacific Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Quetiapine Fumarate Sales by Country (2019-2030)
5.6.3 Asia Pacific Quetiapine Fumarate Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Quetiapine Fumarate Market Facts & Figures by Country
5.7.1 Latin America Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Quetiapine Fumarate Sales by Country (2019-2030)
5.7.3 Latin America Quetiapine Fumarate Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
5.8.1 Middle East and Africa Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Quetiapine Fumarate Sales by Country (2019-2030)
5.8.3 Middle East and Africa Quetiapine Fumarate Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Quetiapine Fumarate Sales by Type (2019-2030)
6.1.1 Global Quetiapine Fumarate Sales by Type (2019-2030) & (MT)
6.1.2 Global Quetiapine Fumarate Sales Market Share by Type (2019-2030)
6.2 Global Quetiapine Fumarate Revenue by Type (2019-2030)
6.2.1 Global Quetiapine Fumarate Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Quetiapine Fumarate Revenue Market Share by Type (2019-2030)
6.3 Global Quetiapine Fumarate Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Quetiapine Fumarate Sales by Application (2019-2030)
7.1.1 Global Quetiapine Fumarate Sales by Application (2019-2030) & (MT)
7.1.2 Global Quetiapine Fumarate Sales Market Share by Application (2019-2030)
7.2 Global Quetiapine Fumarate Revenue by Application (2019-2030)
7.2.1 Global Quetiapine Fumarate Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Quetiapine Fumarate Revenue Market Share by Application (2019-2030)
7.3 Global Quetiapine Fumarate Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Quetiapine Fumarate Value Chain Analysis
8.1.1 Quetiapine Fumarate Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Quetiapine Fumarate Production Mode & Process
8.2 Quetiapine Fumarate Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Quetiapine Fumarate Distributors
8.2.3 Quetiapine Fumarate Customers
9 GLOBAL QUETIAPINE FUMARATE ANALYZING MARKET DYNAMICS
9.1 Quetiapine Fumarate Industry Trends
9.2 Quetiapine Fumarate Industry Drivers
9.3 Quetiapine Fumarate Industry Opportunities and Challenges
9.4 Quetiapine Fumarate Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Quetiapine Fumarate Market Size (2019-2030) & (US$ Million)
2.2.2 Global Quetiapine Fumarate Sales (2019-2030)
2.2.3 Global Quetiapine Fumarate Market Average Price (2019-2030)
2.3 Quetiapine Fumarate by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Immediate Release Tablets
2.3.3 Extended Release Tablets
2.4 Quetiapine Fumarate by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Adult
2.4.3 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Quetiapine Fumarate Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Quetiapine Fumarate Sales (MT) of Manufacturers (2019-2024)
3.3 Global Quetiapine Fumarate Revenue of Manufacturers (2019-2024)
3.4 Global Quetiapine Fumarate Average Price by Manufacturers (2019-2024)
3.5 Global Quetiapine Fumarate Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Quetiapine Fumarate, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Quetiapine Fumarate, Product Type & Application
3.8 Global Manufacturers of Quetiapine Fumarate, Date of Enter into This Industry
3.9 Global Quetiapine Fumarate Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 AstraZeneca
4.1.1 AstraZeneca Company Information
4.1.2 AstraZeneca Business Overview
4.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
4.1.5 AstraZeneca Recent Developments
4.2 Intas
4.2.1 Intas Company Information
4.2.2 Intas Business Overview
4.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Intas Quetiapine Fumarate Product Portfolio
4.2.5 Intas Recent Developments
4.3 TAPI
4.3.1 TAPI Company Information
4.3.2 TAPI Business Overview
4.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.3.4 TAPI Quetiapine Fumarate Product Portfolio
4.3.5 TAPI Recent Developments
4.4 Accord
4.4.1 Accord Company Information
4.4.2 Accord Business Overview
4.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Accord Quetiapine Fumarate Product Portfolio
4.4.5 Accord Recent Developments
4.5 Hexal
4.5.1 Hexal Company Information
4.5.2 Hexal Business Overview
4.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Hexal Quetiapine Fumarate Product Portfolio
4.5.5 Hexal Recent Developments
4.6 Dr.Reddy's
4.6.1 Dr.Reddy's Company Information
4.6.2 Dr.Reddy's Business Overview
4.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
4.6.5 Dr.Reddy's Recent Developments
4.7 Lupin
4.7.1 Lupin Company Information
4.7.2 Lupin Business Overview
4.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Lupin Quetiapine Fumarate Product Portfolio
4.7.5 Lupin Recent Developments
4.8 Sun Pharmaceutical
4.8.1 Sun Pharmaceutical Company Information
4.8.2 Sun Pharmaceutical Business Overview
4.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
4.8.5 Sun Pharmaceutical Recent Developments
4.9 Hunan Dongting Pharm
4.9.1 Hunan Dongting Pharm Company Information
4.9.2 Hunan Dongting Pharm Business Overview
4.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
4.9.5 Hunan Dongting Pharm Recent Developments
4.10 SuZhou NO.4 Phamaceutical Factory
4.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
4.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
4.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
4.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
4.11 Fuan Pharmaceutical
4.11.1 Fuan Pharmaceutical Company Information
4.11.2 Fuan Pharmaceutical Business Overview
4.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
4.11.5 Fuan Pharmaceutical Recent Developments
4.12 Zhejiang Supor Pharmaceuticals
4.12.1 Zhejiang Supor Pharmaceuticals Company Information
4.12.2 Zhejiang Supor Pharmaceuticals Business Overview
4.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
4.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
4.13 Zhejiang Huahai Pharmaceutical
4.13.1 Zhejiang Huahai Pharmaceutical Company Information
4.13.2 Zhejiang Huahai Pharmaceutical Business Overview
4.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
4.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
5 GLOBAL QUETIAPINE FUMARATE MARKET SCENARIO BY REGION
5.1 Global Quetiapine Fumarate Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Quetiapine Fumarate Sales by Region: 2019-2030
5.2.1 Global Quetiapine Fumarate Sales by Region: 2019-2024
5.2.2 Global Quetiapine Fumarate Sales by Region: 2025-2030
5.3 Global Quetiapine Fumarate Revenue by Region: 2019-2030
5.3.1 Global Quetiapine Fumarate Revenue by Region: 2019-2024
5.3.2 Global Quetiapine Fumarate Revenue by Region: 2025-2030
5.4 North America Quetiapine Fumarate Market Facts & Figures by Country
5.4.1 North America Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Quetiapine Fumarate Sales by Country (2019-2030)
5.4.3 North America Quetiapine Fumarate Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Quetiapine Fumarate Market Facts & Figures by Country
5.5.1 Europe Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Quetiapine Fumarate Sales by Country (2019-2030)
5.5.3 Europe Quetiapine Fumarate Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Country
5.6.1 Asia Pacific Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Quetiapine Fumarate Sales by Country (2019-2030)
5.6.3 Asia Pacific Quetiapine Fumarate Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Quetiapine Fumarate Market Facts & Figures by Country
5.7.1 Latin America Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Quetiapine Fumarate Sales by Country (2019-2030)
5.7.3 Latin America Quetiapine Fumarate Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
5.8.1 Middle East and Africa Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Quetiapine Fumarate Sales by Country (2019-2030)
5.8.3 Middle East and Africa Quetiapine Fumarate Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Quetiapine Fumarate Sales by Type (2019-2030)
6.1.1 Global Quetiapine Fumarate Sales by Type (2019-2030) & (MT)
6.1.2 Global Quetiapine Fumarate Sales Market Share by Type (2019-2030)
6.2 Global Quetiapine Fumarate Revenue by Type (2019-2030)
6.2.1 Global Quetiapine Fumarate Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Quetiapine Fumarate Revenue Market Share by Type (2019-2030)
6.3 Global Quetiapine Fumarate Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Quetiapine Fumarate Sales by Application (2019-2030)
7.1.1 Global Quetiapine Fumarate Sales by Application (2019-2030) & (MT)
7.1.2 Global Quetiapine Fumarate Sales Market Share by Application (2019-2030)
7.2 Global Quetiapine Fumarate Revenue by Application (2019-2030)
7.2.1 Global Quetiapine Fumarate Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Quetiapine Fumarate Revenue Market Share by Application (2019-2030)
7.3 Global Quetiapine Fumarate Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Quetiapine Fumarate Value Chain Analysis
8.1.1 Quetiapine Fumarate Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Quetiapine Fumarate Production Mode & Process
8.2 Quetiapine Fumarate Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Quetiapine Fumarate Distributors
8.2.3 Quetiapine Fumarate Customers
9 GLOBAL QUETIAPINE FUMARATE ANALYZING MARKET DYNAMICS
9.1 Quetiapine Fumarate Industry Trends
9.2 Quetiapine Fumarate Industry Drivers
9.3 Quetiapine Fumarate Industry Opportunities and Challenges
9.4 Quetiapine Fumarate Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
